Mahesh Menon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mahesh Menon has a total of 93 co-authors. Here are the top co-authors by number of shared publications:
- Katie M. Lavigne
Douglas Research Centre
6 shared publications - Martin Lepage
Douglas Research Centre
6 shared publications - Todd Stephen Woodward
University of British Columbia
6 shared publications - Abhijit Mahesh Chinchani
University of British Columbia
4 shared publications - Delphine Raucher-Chéné
Douglas Research Centre
4 shared publications - Ivan J. Torres
University of British Columbia
4 shared publications
Latest Publications
- Open Access
- 6 October 2026
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 204, 28-37
Cognitive predictors of functioning and treatment response in treatment-resistant psychosis: A transdiagnostic approach
- 6 October 2026
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 204, 28-37
Open AccessCognitive predictors of functioning and treatment response in treatment-resistant psychosis: A transdiagnostic approach
- 7 September 2026
- Published by SAGE Publications in The Canadian Journal of Psychiatry
A Multivariate Approach to Communication Impoverishment and Cognitive Performance in Treatment-Resistant Schizophrenia: Analyse à plusieurs variables portant sur l’appauvrissement de la communication et la performance cognitive dans les cas de schizophrénie résistante au traitement
Objective: Language and communication disturbances are enduring features of schizophrenia, often manifesting as impoverishment of speech. This exploratory study aims to examine how communicative deficits overlap with a cognitive profile of treatment-resistant chronic schizophrenia inpatients. Methods: We employed Iterative Constrained Principal Component Analysis in a sample of inpatients ( n = 138) to identify the optimized, multidimensional overlap between 17 neuropsychological measures and 26 symptom items from the Positive and Negative Syndrome Scale. Cognition was assessed via neuropsychological tests of verbal comprehension, semantic memory/verbal fluency, cognitive flexibility, verbal and visuospatial learning, processing speed, and working memory. Results: The analysis identified a distinct symptom-cognition cluster. Communication Impoverishment (specifically the Lack of Spontaneity and Flow of Conversation) was the primary predictor of a cognitive component characterized by Verbal Fluency and Executive Functioning. This component was defined by performance on tasks measuring category-based word generation, the ability to switch between semantic rules, and the depth of word knowledge and general factual information. This association was independent of antipsychotic dosage and correlated with real-world social and occupational functioning. Conclusions: The results indicate that communication impoverishment in persistent psychosis reflects dysfunction within the verbal-semantic system, likely involving both the fluid executive ability to navigate categories and the integrity of the semantic store itself.
- 7 September 2026
- Published by SAGE Publications in The Canadian Journal of Psychiatry
A Multivariate Approach to Communication Impoverishment and Cognitive Performance in Treatment-Resistant Schizophrenia: Analyse à plusieurs variables portant sur l’appauvrissement de la communication et la performance cognitive dans les cas de schizophrénie résistante au traitement
Objective: Language and communication disturbances are enduring features of schizophrenia, often manifesting as impoverishment of speech. This exploratory study aims to examine how communicative deficits overlap with a cognitive profile of treatment-resistant chronic schizophrenia inpatients. Methods: We employed Iterative Constrained Principal Component Analysis in a sample of inpatients ( n = 138) to identify the optimized, multidimensional overlap between 17 neuropsychological measures and 26 symptom items from the Positive and Negative Syndrome Scale. Cognition was assessed via neuropsychological tests of verbal comprehension, semantic memory/verbal fluency, cognitive flexibility, verbal and visuospatial learning, processing speed, and working memory. Results: The analysis identified a distinct symptom-cognition cluster. Communication Impoverishment (specifically the Lack of Spontaneity and Flow of Conversation) was the primary predictor of a cognitive component characterized by Verbal Fluency and Executive Functioning. This component was defined by performance on tasks measuring category-based word generation, the ability to switch between semantic rules, and the depth of word knowledge and general factual information. This association was independent of antipsychotic dosage and correlated with real-world social and occupational functioning. Conclusions: The results indicate that communication impoverishment in persistent psychosis reflects dysfunction within the verbal-semantic system, likely involving both the fluid executive ability to navigate categories and the integrity of the semantic store itself.
- Open Access
- 4 May 2026
- Published by Center for Open Science in PsyArXiv
Beliefs without Strong Supporting Evidence: Associations with Personality Items
Beliefs without strong supporting evidence (BWSSE), such as conspiracy theories and pseudoscientific beliefs, are increasingly common, and their growing prevalence may have negative consequences for society. The design of more effective interventions to mitigate the spread of BWSSE may depend on understanding the personality characteristics associated with different belief types. To meet this goal, this study optimized components from a BWSSE questionnaire with respect to overlap with the Big Five Aspect Scale (BFAS), which assesses personality. Data from 417 participants who completed the BWSSE questionnaire and BFAS within standard completion times were analyzed using a multivariate statistical method to identify how individual BFAS items, rather than aggregate domain scores, were associated with the BWSSE questionnaire components optimized for overlap with the BFAS. We found that New Age beliefs were associated with creativity and emotional sensitivity (primarily items from the Openness and Agreeableness domains), Science beliefs with a preference for order, routine and systematic thinking (primarily items from the Conscientiousness and Intellect domains), Traditional Religion with respect for authority and a less expansive vocabulary (primarily items from the Agreeableness and Intellect domains), and Conspiracy Theories with enjoying conflict and easily becoming angered and agitated (primarily items from the Neuroticism domain). Different belief types were associated with distinct combinations of individual BFAS items that crossed BFAS domains, highlighting within-domain dissociations that are obscured when using aggregate domain scores. These belief-personality associations, combined with reasons for holding BWSSE, should be considered when developing strategies to reduce misinformation and promote evidence-based reasoning.
- 4 May 2026
- Published by Center for Open Science in PsyArXiv
Open AccessBeliefs without Strong Supporting Evidence: Associations with Personality Items
Beliefs without strong supporting evidence (BWSSE), such as conspiracy theories and pseudoscientific beliefs, are increasingly common, and their growing prevalence may have negative consequences for society. The design of more effective interventions to mitigate the spread of BWSSE may depend on understanding the personality characteristics associated with different belief types. To meet this goal, this study optimized components from a BWSSE questionnaire with respect to overlap with the Big Five Aspect Scale (BFAS), which assesses personality. Data from 417 participants who completed the BWSSE questionnaire and BFAS within standard completion times were analyzed using a multivariate statistical method to identify how individual BFAS items, rather than aggregate domain scores, were associated with the BWSSE questionnaire components optimized for overlap with the BFAS. We found that New Age beliefs were associated with creativity and emotional sensitivity (primarily items from the Openness and Agreeableness domains), Science beliefs with a preference for order, routine and systematic thinking (primarily items from the Conscientiousness and Intellect domains), Traditional Religion with respect for authority and a less expansive vocabulary (primarily items from the Agreeableness and Intellect domains), and Conspiracy Theories with enjoying conflict and easily becoming angered and agitated (primarily items from the Neuroticism domain). Different belief types were associated with distinct combinations of individual BFAS items that crossed BFAS domains, highlighting within-domain dissociations that are obscured when using aggregate domain scores. These belief-personality associations, combined with reasons for holding BWSSE, should be considered when developing strategies to reduce misinformation and promote evidence-based reasoning.
- Open Access
- 29 January 2026
- Published by Organization for Human Brain Mapping in Aperture Neuro
- Vol. 6 (SI 1)
From episodic memory to functioning in schizophrenia and related psychoses: A neurocognitive model - protocol paper
Across all stages of schizophrenia and related psychoses, impairments in episodic memory predict poor outcomes. Previous research has posited the hippocampus as a key brain region for understanding both negative symptoms and episodic memory. Our team proposed that hippocampal dysconnectivity impairs episodic memory, which in turn negatively affects social cognitive abilities and enhances the presence of negative symptoms (e.g., asociality, apathy), affecting functional outcome. While we were able to provide preliminary evidence for such a temporal progression, an investigation of this model considering a structural and functional assessment of hippocampal connectivity and controlling for important moderating factors including sex and illness chronicity is currently lacking. To validate this model, we will generate a multisite dataset consisting of 300 individuals with schizophrenia spectrum disorder or bipolar I disorder with psychosis and 150 non-clinical controls, to determine multimodal hippocampal connectivity, memory impairments, functional outcome, and potential mediating/moderating factors (e.g., social cognition, negative symptoms). The machine learning algorithm Subtype and Stage Inference will be applied to unravel data-driven disease phenotypes with temporal progression patterns and enable individual-level predictions. To promote open science principles, the resulting dataset and analytic code will be made publicly available. This study combines both data-driven and hypothesis-driven approaches to provide a novel mechanistic account of how memory impairments impact functioning in individuals with psychotic disorders. It also follows a translational framework aiming to reduce heterogeneity in biomarker discovery and promote precision psychiatry. The resulting open dataset and code will advance open science in psychiatric illness. Our open resources will pave the way for large-scale initiatives in psychosis and mental health research, supporting international collaborations and new analytical perspectives.
- 29 January 2026
- Published by Organization for Human Brain Mapping in Aperture Neuro
- Vol. 6 (SI 1)
Open AccessFrom episodic memory to functioning in schizophrenia and related psychoses: A neurocognitive model - protocol paper
Across all stages of schizophrenia and related psychoses, impairments in episodic memory predict poor outcomes. Previous research has posited the hippocampus as a key brain region for understanding both negative symptoms and episodic memory. Our team proposed that hippocampal dysconnectivity impairs episodic memory, which in turn negatively affects social cognitive abilities and enhances the presence of negative symptoms (e.g., asociality, apathy), affecting functional outcome. While we were able to provide preliminary evidence for such a temporal progression, an investigation of this model considering a structural and functional assessment of hippocampal connectivity and controlling for important moderating factors including sex and illness chronicity is currently lacking. To validate this model, we will generate a multisite dataset consisting of 300 individuals with schizophrenia spectrum disorder or bipolar I disorder with psychosis and 150 non-clinical controls, to determine multimodal hippocampal connectivity, memory impairments, functional outcome, and potential mediating/moderating factors (e.g., social cognition, negative symptoms). The machine learning algorithm Subtype and Stage Inference will be applied to unravel data-driven disease phenotypes with temporal progression patterns and enable individual-level predictions. To promote open science principles, the resulting dataset and analytic code will be made publicly available. This study combines both data-driven and hypothesis-driven approaches to provide a novel mechanistic account of how memory impairments impact functioning in individuals with psychotic disorders. It also follows a translational framework aiming to reduce heterogeneity in biomarker discovery and promote precision psychiatry. The resulting open dataset and code will advance open science in psychiatric illness. Our open resources will pave the way for large-scale initiatives in psychosis and mental health research, supporting international collaborations and new analytical perspectives.
- Open Access
- 22 October 2025
- Published by SAGE Publications in The Canadian Journal of Psychiatry
- Vol. 71 (3) , 199-209
A multisite study of the overlap between symptoms and cognition in schizophrenia: Une étude multicentrique sur le chevauchement entre les symptômes et les troubles cognitifs chez les personnes atteintes de schizophrénie
Objective: Cognitive impairment is a core feature of schizophrenia spectrum disorders. Our previous study on a first-episode psychosis cohort showed that symptoms related to impoverished/disorganized communication and motor impoverishment predicted verbal and working memory scores, respectively. This study aimed to explore those predictors in people across the range of illness chronicity. Methods: We employed iterative Constrained Principal Component Analysis (iCPCA) to investigate the relationship between 15 cognitive measures from the MATRICS battery, including processing speed, attention, working, verbal and nonverbal memory, reasoning, and problem-solving, and 27 Positive and Negative Syndrome Scale (PANSS) items in 198 outpatients from two sites in Australia and one in Canada. The iCPCA method was used to determine symptoms that reliably predict specific combinations of cognitive measures while controlling Type I errors. Results: We found that a verbal memory and learning component was predicted by the PANSS item Lack of Spontaneity and Flow of Conversation , and a visual attention/working memory component was linked to the PANSS item Motor Retardation . Conclusions: These accord with our previous findings in an early psychosis sample, that is, negative symptoms of diminished expression are key predictors of cognitive abilities in schizophrenia. Namely, communication and motor impoverishments predicted lower scores on tests of verbal memory, learning, visual attention, and working memory. These findings may inform personalized treatment approaches targeting cognitive deficits and negative symptoms in schizophrenia.
- 22 October 2025
- Published by SAGE Publications in The Canadian Journal of Psychiatry
- Vol. 71 (3) , 199-209
Open AccessA multisite study of the overlap between symptoms and cognition in schizophrenia: Une étude multicentrique sur le chevauchement entre les symptômes et les troubles cognitifs chez les personnes atteintes de schizophrénie
Objective: Cognitive impairment is a core feature of schizophrenia spectrum disorders. Our previous study on a first-episode psychosis cohort showed that symptoms related to impoverished/disorganized communication and motor impoverishment predicted verbal and working memory scores, respectively. This study aimed to explore those predictors in people across the range of illness chronicity. Methods: We employed iterative Constrained Principal Component Analysis (iCPCA) to investigate the relationship between 15 cognitive measures from the MATRICS battery, including processing speed, attention, working, verbal and nonverbal memory, reasoning, and problem-solving, and 27 Positive and Negative Syndrome Scale (PANSS) items in 198 outpatients from two sites in Australia and one in Canada. The iCPCA method was used to determine symptoms that reliably predict specific combinations of cognitive measures while controlling Type I errors. Results: We found that a verbal memory and learning component was predicted by the PANSS item Lack of Spontaneity and Flow of Conversation , and a visual attention/working memory component was linked to the PANSS item Motor Retardation . Conclusions: These accord with our previous findings in an early psychosis sample, that is, negative symptoms of diminished expression are key predictors of cognitive abilities in schizophrenia. Namely, communication and motor impoverishments predicted lower scores on tests of verbal memory, learning, visual attention, and working memory. These findings may inform personalized treatment approaches targeting cognitive deficits and negative symptoms in schizophrenia.
- Open Access
- 15 April 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e63269
iCogCA to Promote Cognitive Health Through Digital Group Interventions for Individuals Living With a Schizophrenia Spectrum Disorder: Protocol for a Nonrandomized Concurrent Controlled Trial
Background: Cognitive impairments are a key aspect of schizophrenia spectrum disorders (SSDs), significantly affecting clinical and functional outcomes. The COVID-19 pandemic has heightened concerns about mental health services and cognitive stimulation opportunities. Despite evidence-based interventions like action-based cognitive remediation (ABCR) and metacognitive training (MCT), a research-to-practice gap exists in their application across mental health settings. Objective: The iCogCA study aims to address this gap by implementing digital ABCR and MCT through a national Canadian collaborative effort using digital psychological interventions to enhance cognitive health in SSDs. Methods: The study involves 5 Canadian sites, with mental health care practitioners trained digitally through the E-Cog platform, which was developed by our research group. Over 2.5 years, participants with SSDs will undergo pre- and postintervention assessments for clinical symptoms, cognition, and functioning. Each site will run groups annually for both ABCR and MCT, totaling ~390 participants. A nonrandomized concurrent controlled design will assess effectiveness design, in which one intervention (eg, ABCR) acts as the active control for the other (eg, MCT) and vice versa, comparing cognitive and clinical outcomes between the interventions using generalized linear mixed effect modeling. Implementation strategy evaluation will consider the digital platform’s efficacy for mental health care practitioners’ training, contextual factors influencing implementation, and sustainability, using descriptive statistics for quantitative data and thematic analysis for qualitative data. Results: A pilot pragmatic trial has been conducted previously at the Montreal site, evaluating 3 early implementation outcomes: acceptability, feasibility, and engagement. Patient and therapist acceptability was deemed as high and feasible (21/28, 75% of recruited service users completed therapy, rated feasible by therapists). Technology did not appear to significantly impede program participation. Therapist-rated levels of engagement were also satisfactory. In the ongoing study, recruitment is underway (114 participants recruited as of winter 2024), and intervention groups have been conducted at all sites, with therapists receiving training via the E-Cog learning platform (32 enrolled as of winter 2024). Conclusions: At least 3 significant innovations will stem from this project. First, this national effort represents a catalyst for the use of digital technologies to increase the adoption of evidence-based interventions and will provide important results on the effectiveness of digitally delivered ABCR and MCT. Second, the results of the implementation component of this study will generate the expertise needed to inform the implementation of similar initiatives. Third, the proposed study will introduce and validate our platform to train and supervise mental health care practitioners to deliver these interventions, which will then be made accessible to the broader mental health community. Trial Registration: ClinicalTrials.gov NCT05661448; https://clinicaltrials.gov/study/NCT05661448 International Registered Report Identifier (IRRID): DERR1-10.2196/63269
- 15 April 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e63269
Open AccessiCogCA to Promote Cognitive Health Through Digital Group Interventions for Individuals Living With a Schizophrenia Spectrum Disorder: Protocol for a Nonrandomized Concurrent Controlled Trial
Background: Cognitive impairments are a key aspect of schizophrenia spectrum disorders (SSDs), significantly affecting clinical and functional outcomes. The COVID-19 pandemic has heightened concerns about mental health services and cognitive stimulation opportunities. Despite evidence-based interventions like action-based cognitive remediation (ABCR) and metacognitive training (MCT), a research-to-practice gap exists in their application across mental health settings. Objective: The iCogCA study aims to address this gap by implementing digital ABCR and MCT through a national Canadian collaborative effort using digital psychological interventions to enhance cognitive health in SSDs. Methods: The study involves 5 Canadian sites, with mental health care practitioners trained digitally through the E-Cog platform, which was developed by our research group. Over 2.5 years, participants with SSDs will undergo pre- and postintervention assessments for clinical symptoms, cognition, and functioning. Each site will run groups annually for both ABCR and MCT, totaling ~390 participants. A nonrandomized concurrent controlled design will assess effectiveness design, in which one intervention (eg, ABCR) acts as the active control for the other (eg, MCT) and vice versa, comparing cognitive and clinical outcomes between the interventions using generalized linear mixed effect modeling. Implementation strategy evaluation will consider the digital platform’s efficacy for mental health care practitioners’ training, contextual factors influencing implementation, and sustainability, using descriptive statistics for quantitative data and thematic analysis for qualitative data. Results: A pilot pragmatic trial has been conducted previously at the Montreal site, evaluating 3 early implementation outcomes: acceptability, feasibility, and engagement. Patient and therapist acceptability was deemed as high and feasible (21/28, 75% of recruited service users completed therapy, rated feasible by therapists). Technology did not appear to significantly impede program participation. Therapist-rated levels of engagement were also satisfactory. In the ongoing study, recruitment is underway (114 participants recruited as of winter 2024), and intervention groups have been conducted at all sites, with therapists receiving training via the E-Cog learning platform (32 enrolled as of winter 2024). Conclusions: At least 3 significant innovations will stem from this project. First, this national effort represents a catalyst for the use of digital technologies to increase the adoption of evidence-based interventions and will provide important results on the effectiveness of digitally delivered ABCR and MCT. Second, the results of the implementation component of this study will generate the expertise needed to inform the implementation of similar initiatives. Third, the proposed study will introduce and validate our platform to train and supervise mental health care practitioners to deliver these interventions, which will then be made accessible to the broader mental health community. Trial Registration: ClinicalTrials.gov NCT05661448; https://clinicaltrials.gov/study/NCT05661448 International Registered Report Identifier (IRRID): DERR1-10.2196/63269
- Open Access
- 4 September 2024
- Published by Center for Open Science in PsyArXiv
Testing the overlap between symptoms and cognition in schizophrenia: A multi-site study
Background and Hypothesis. Cognitive impairment is a core feature of schizophrenia spectrum disorders (SSD). While the relationship between cognition and symptoms in SSD has been extensively studied, there is a lack of research focusing on individual item-level analysis rather than relying on summary score methodology. Our previous study on a first-episode psychosis cohort showed that symptoms related to impoverished and disorganized communication and motor impoverishment were associated with impairments in verbal and working memory. This study aimed to explore those associations in people with chronic schizophrenia.Study Design. We employed iterative Constrained Principal Component Analysis (iCPCA) to investigate the relationship between 15 cognitive measures, including processing speed, attention, working, verbal memory, reasoning, problem-solving and 26 PANSS items in 198 chronic schizophrenia outpatients from two sites in Australia and one in Canada. The iCPCA method was used to determine item combinations optimized to describe associations between symptoms and cognition while controlling Type I errors.Results. Our analysis revealed that a verbal memory component was associated with the PANSS item Lack of Spontaneity and Flow of Conversation, indicating impairments in communication, language, and thought. Additionally, a working memory and attention component was linked to the PANSS item Motor Retardation, reflecting motor system impoverishment.Conclusions. These results confirm our previous findings, showing that negative symptoms of diminished expression are key predictors of cognitive impairments in schizophrenia. These data underscore the value of optimized item combinations in identifying precise symptom-cognition relationships, which can potentially inform more effective treatment strategies.Keywords: schizophrenia, cognition, psychotic symptoms, verbal and working memory, motor impoverishment, disorganized and impoverished communication.
- 4 September 2024
- Published by Center for Open Science in PsyArXiv
Open AccessTesting the overlap between symptoms and cognition in schizophrenia: A multi-site study
Background and Hypothesis. Cognitive impairment is a core feature of schizophrenia spectrum disorders (SSD). While the relationship between cognition and symptoms in SSD has been extensively studied, there is a lack of research focusing on individual item-level analysis rather than relying on summary score methodology. Our previous study on a first-episode psychosis cohort showed that symptoms related to impoverished and disorganized communication and motor impoverishment were associated with impairments in verbal and working memory. This study aimed to explore those associations in people with chronic schizophrenia.Study Design. We employed iterative Constrained Principal Component Analysis (iCPCA) to investigate the relationship between 15 cognitive measures, including processing speed, attention, working, verbal memory, reasoning, problem-solving and 26 PANSS items in 198 chronic schizophrenia outpatients from two sites in Australia and one in Canada. The iCPCA method was used to determine item combinations optimized to describe associations between symptoms and cognition while controlling Type I errors.Results. Our analysis revealed that a verbal memory component was associated with the PANSS item Lack of Spontaneity and Flow of Conversation, indicating impairments in communication, language, and thought. Additionally, a working memory and attention component was linked to the PANSS item Motor Retardation, reflecting motor system impoverishment.Conclusions. These results confirm our previous findings, showing that negative symptoms of diminished expression are key predictors of cognitive impairments in schizophrenia. These data underscore the value of optimized item combinations in identifying precise symptom-cognition relationships, which can potentially inform more effective treatment strategies.Keywords: schizophrenia, cognition, psychotic symptoms, verbal and working memory, motor impoverishment, disorganized and impoverished communication.
- Open Access
- 14 June 2024
- Published by JMIR Publications Inc. in JMIR Preprints
iCogCA to Promote Cognitive Health Through Digital Group Interventions for Individuals Living With a Schizophrenia Spectrum Disorder: Protocol for a Nonrandomized Concurrent Controlled Trial (Preprint)
BACKGROUND Cognitive impairments are a key aspect of schizophrenia spectrum disorders (SSDs), significantly affecting clinical and functional outcomes. The COVID-19 pandemic has heightened concerns about mental health services and cognitive stimulation opportunities. Despite evidence-based interventions like action-based cognitive remediation (ABCR) and metacognitive training (MCT), a research-to-practice gap exists in their application across mental health settings. OBJECTIVE The iCogCA study aims to address this gap by implementing digital ABCR and MCT through a national Canadian collaborative effort using digital psychological interventions to enhance cognitive health in SSDs. METHODS The study involves 5 Canadian sites, with mental health care practitioners trained digitally through the E-Cog platform, which was developed by our research group. Over 2.5 years, participants with SSDs will undergo pre- and postintervention assessments for clinical symptoms, cognition, and functioning. Each site will run groups annually for both ABCR and MCT, totaling ~390 participants. A nonrandomized concurrent controlled design will assess effectiveness design, in which one intervention (eg, ABCR) acts as the active control for the other (eg, MCT) and vice versa, comparing cognitive and clinical outcomes between the interventions using generalized linear mixed effect modeling. Implementation strategy evaluation will consider the digital platform’s efficacy for mental health care practitioners’ training, contextual factors influencing implementation, and sustainability, using descriptive statistics for quantitative data and thematic analysis for qualitative data. RESULTS A pilot pragmatic trial has been conducted previously at the Montreal site, evaluating 3 early implementation outcomes: acceptability, feasibility, and engagement. Patient and therapist acceptability was deemed as high and feasible (21/28, 75% of recruited service users completed therapy, rated feasible by therapists). Technology did not appear to significantly impede program participation. Therapist-rated levels of engagement were also satisfactory. In the ongoing study, recruitment is underway (114 participants recruited as of winter 2024), and intervention groups have been conducted at all sites, with therapists receiving training via the E-Cog learning platform (32 enrolled as of winter 2024). CONCLUSIONS At least 3 significant innovations will stem from this project. First, this national effort represents a catalyst for the use of digital technologies to increase the adoption of evidence-based interventions and will provide important results on the effectiveness of digitally delivered ABCR and MCT. Second, the results of the implementation component of this study will generate the expertise needed to inform the implementation of similar initiatives. Third, the proposed study will introduce and validate our platform to train and supervise mental health care practitioners to deliver these interventions, which will then be made accessible to the broader mental health community. CLINICALTRIAL ClinicalTrials.gov NCT05661448; https://clinicaltrials.gov/study/NCT05661448 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/63269
- 14 June 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessiCogCA to Promote Cognitive Health Through Digital Group Interventions for Individuals Living With a Schizophrenia Spectrum Disorder: Protocol for a Nonrandomized Concurrent Controlled Trial (Preprint)
BACKGROUND Cognitive impairments are a key aspect of schizophrenia spectrum disorders (SSDs), significantly affecting clinical and functional outcomes. The COVID-19 pandemic has heightened concerns about mental health services and cognitive stimulation opportunities. Despite evidence-based interventions like action-based cognitive remediation (ABCR) and metacognitive training (MCT), a research-to-practice gap exists in their application across mental health settings. OBJECTIVE The iCogCA study aims to address this gap by implementing digital ABCR and MCT through a national Canadian collaborative effort using digital psychological interventions to enhance cognitive health in SSDs. METHODS The study involves 5 Canadian sites, with mental health care practitioners trained digitally through the E-Cog platform, which was developed by our research group. Over 2.5 years, participants with SSDs will undergo pre- and postintervention assessments for clinical symptoms, cognition, and functioning. Each site will run groups annually for both ABCR and MCT, totaling ~390 participants. A nonrandomized concurrent controlled design will assess effectiveness design, in which one intervention (eg, ABCR) acts as the active control for the other (eg, MCT) and vice versa, comparing cognitive and clinical outcomes between the interventions using generalized linear mixed effect modeling. Implementation strategy evaluation will consider the digital platform’s efficacy for mental health care practitioners’ training, contextual factors influencing implementation, and sustainability, using descriptive statistics for quantitative data and thematic analysis for qualitative data. RESULTS A pilot pragmatic trial has been conducted previously at the Montreal site, evaluating 3 early implementation outcomes: acceptability, feasibility, and engagement. Patient and therapist acceptability was deemed as high and feasible (21/28, 75% of recruited service users completed therapy, rated feasible by therapists). Technology did not appear to significantly impede program participation. Therapist-rated levels of engagement were also satisfactory. In the ongoing study, recruitment is underway (114 participants recruited as of winter 2024), and intervention groups have been conducted at all sites, with therapists receiving training via the E-Cog learning platform (32 enrolled as of winter 2024). CONCLUSIONS At least 3 significant innovations will stem from this project. First, this national effort represents a catalyst for the use of digital technologies to increase the adoption of evidence-based interventions and will provide important results on the effectiveness of digitally delivered ABCR and MCT. Second, the results of the implementation component of this study will generate the expertise needed to inform the implementation of similar initiatives. Third, the proposed study will introduce and validate our platform to train and supervise mental health care practitioners to deliver these interventions, which will then be made accessible to the broader mental health community. CLINICALTRIAL ClinicalTrials.gov NCT05661448; https://clinicaltrials.gov/study/NCT05661448 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/63269
- Open Access
- 7 April 2023
- Published by JMIR Publications Inc. in JMIR Serious Games
- Vol. 11 (1) , e43904
Co-design of a Virtual Reality Cognitive Remediation Program for Depression (bWell-D) With Patient End Users and Clinicians: Qualitative Interview Study Among Patients and Clinicians
Background: Major depressive disorder (MDD) is the leading cause of global disability; however, the existing treatments do not always address cognitive dysfunction—a core feature of MDD. Immersive virtual reality (VR) has emerged as a promising modality to enhance the real-world effectiveness of cognitive remediation. Objective: This study aimed to develop the first prototype VR cognitive remediation program for MDD (“bWell-D”). This study gathered qualitative data from end users early in the design process to enhance its efficacy and feasibility in clinical settings. Methods: Semistructured end-user interviews were conducted remotely (n=15 patients and n=12 clinicians), assessing the participants’ perceptions and goals for a VR cognitive remediation program. Video samples of bWell-D were also shared to obtain feedback regarding the program. The interviews were transcribed, coded, and analyzed via thematic analysis. Results: End users showed an optimistic outlook toward VR as a treatment modality, and perceived it as a novel approach with the potential of having multiple applications. The participants expressed a need for an engaging VR treatment that included realistic and multisensorial settings and activities, as well as customizable features. Some skepticism regarding its effectiveness was also reported, especially when the real-world applications of the practiced skills were not made explicit, as well as some concerns regarding equipment accessibility. A home-based or hybrid (ie, home and clinic) treatment modality was preferred. Conclusions: Patients and clinicians considered bWell-D interesting, acceptable, and potentially feasible, and provided suggestions to enhance its real-world applicability. The inclusion of end-user feedback is encouraged when developing future VR programs for clinical purposes.
- 7 April 2023
- Published by JMIR Publications Inc. in JMIR Serious Games
- Vol. 11 (1) , e43904
Open AccessCo-design of a Virtual Reality Cognitive Remediation Program for Depression (bWell-D) With Patient End Users and Clinicians: Qualitative Interview Study Among Patients and Clinicians
Background: Major depressive disorder (MDD) is the leading cause of global disability; however, the existing treatments do not always address cognitive dysfunction—a core feature of MDD. Immersive virtual reality (VR) has emerged as a promising modality to enhance the real-world effectiveness of cognitive remediation. Objective: This study aimed to develop the first prototype VR cognitive remediation program for MDD (“bWell-D”). This study gathered qualitative data from end users early in the design process to enhance its efficacy and feasibility in clinical settings. Methods: Semistructured end-user interviews were conducted remotely (n=15 patients and n=12 clinicians), assessing the participants’ perceptions and goals for a VR cognitive remediation program. Video samples of bWell-D were also shared to obtain feedback regarding the program. The interviews were transcribed, coded, and analyzed via thematic analysis. Results: End users showed an optimistic outlook toward VR as a treatment modality, and perceived it as a novel approach with the potential of having multiple applications. The participants expressed a need for an engaging VR treatment that included realistic and multisensorial settings and activities, as well as customizable features. Some skepticism regarding its effectiveness was also reported, especially when the real-world applications of the practiced skills were not made explicit, as well as some concerns regarding equipment accessibility. A home-based or hybrid (ie, home and clinic) treatment modality was preferred. Conclusions: Patients and clinicians considered bWell-D interesting, acceptable, and potentially feasible, and provided suggestions to enhance its real-world applicability. The inclusion of end-user feedback is encouraged when developing future VR programs for clinical purposes.
- Open Access
- 28 October 2022
- Published by JMIR Publications Inc. in JMIR Preprints
Co-design of a Virtual Reality Cognitive Remediation Program for Depression (bWell-D) With Patient End Users and Clinicians: Qualitative Interview Study Among Patients and Clinicians (Preprint)
BACKGROUND Major depressive disorder (MDD) is the leading cause of global disability; however, the existing treatments do not always address cognitive dysfunction—a core feature of MDD. Immersive virtual reality (VR) has emerged as a promising modality to enhance the real-world effectiveness of cognitive remediation. OBJECTIVE This study aimed to develop the first prototype VR cognitive remediation program for MDD (“bWell-D”). This study gathered qualitative data from end users early in the design process to enhance its efficacy and feasibility in clinical settings. METHODS Semistructured end-user interviews were conducted remotely (n=15 patients and n=12 clinicians), assessing the participants’ perceptions and goals for a VR cognitive remediation program. Video samples of bWell-D were also shared to obtain feedback regarding the program. The interviews were transcribed, coded, and analyzed via thematic analysis. RESULTS End users showed an optimistic outlook toward VR as a treatment modality, and perceived it as a novel approach with the potential of having multiple applications. The participants expressed a need for an engaging VR treatment that included realistic and multisensorial settings and activities, as well as customizable features. Some skepticism regarding its effectiveness was also reported, especially when the real-world applications of the practiced skills were not made explicit, as well as some concerns regarding equipment accessibility. A home-based or hybrid (ie, home and clinic) treatment modality was preferred. CONCLUSIONS Patients and clinicians considered bWell-D interesting, acceptable, and potentially feasible, and provided suggestions to enhance its real-world applicability. The inclusion of end-user feedback is encouraged when developing future VR programs for clinical purposes.
- 28 October 2022
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessCo-design of a Virtual Reality Cognitive Remediation Program for Depression (bWell-D) With Patient End Users and Clinicians: Qualitative Interview Study Among Patients and Clinicians (Preprint)
BACKGROUND Major depressive disorder (MDD) is the leading cause of global disability; however, the existing treatments do not always address cognitive dysfunction—a core feature of MDD. Immersive virtual reality (VR) has emerged as a promising modality to enhance the real-world effectiveness of cognitive remediation. OBJECTIVE This study aimed to develop the first prototype VR cognitive remediation program for MDD (“bWell-D”). This study gathered qualitative data from end users early in the design process to enhance its efficacy and feasibility in clinical settings. METHODS Semistructured end-user interviews were conducted remotely (n=15 patients and n=12 clinicians), assessing the participants’ perceptions and goals for a VR cognitive remediation program. Video samples of bWell-D were also shared to obtain feedback regarding the program. The interviews were transcribed, coded, and analyzed via thematic analysis. RESULTS End users showed an optimistic outlook toward VR as a treatment modality, and perceived it as a novel approach with the potential of having multiple applications. The participants expressed a need for an engaging VR treatment that included realistic and multisensorial settings and activities, as well as customizable features. Some skepticism regarding its effectiveness was also reported, especially when the real-world applications of the practiced skills were not made explicit, as well as some concerns regarding equipment accessibility. A home-based or hybrid (ie, home and clinic) treatment modality was preferred. CONCLUSIONS Patients and clinicians considered bWell-D interesting, acceptable, and potentially feasible, and provided suggestions to enhance its real-world applicability. The inclusion of end-user feedback is encouraged when developing future VR programs for clinical purposes.